Worldpay From FIS Opens New Growth Opportunities with United Arab Emirates Expansion

Worldpay From FIS Opens New Growth Opportunities with United Arab Emirates Expansion

Key facts

  • Worldpay from FIS continues to drive global e-commerce with new domestic acquiring capability in the UAE.
  • Expansion is part of business' plans to expand its merchant acquiring presence in key markets.

Continuing to build its footprint as a leading global acquirer, global financial technology leader FIS ® (NYSE: FIS) has announced today its Worldpay merchant business will be expanding its payment processing capabilities into the United Arab Emirates (UAE) this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230426005030/en/

Worldpay has secured a category II payment services license that allows for card acquiring and disbursements. This new domestic license in the UAE will enable the company to offer its world-class payment services to both local companies with global ambitions, and rapidly growing enterprises looking to expand in the market. This comes on the back of its successful expansion into South Korea in 2022 .

Our newest version of The Global Payments Report shows the e-commerce market in the UAE is projected to reach US$43 billion by 2026, with credit cards driving this growth, accounting for 41% of e-commerce transaction value in 2022. This makes it even more important for merchants to select the right payment partner for their business.

"The UAE presents new growth opportunities for global businesses and it's an exciting time to be entering the market," said Gabriel de Montessus, Head of Global Enterprise Merchant Solutions, FIS. "Our new domestic acquiring capability in the UAE will ensure seamless integration into the country for global merchants, while local businesses will benefit from our leading geographic footprint, enabling them to expand globally. Our expertise in payments helps us understand how local consumers prefer to pay, as well as the trends that merchants need to get ahead of to optimize their performance as they enter new markets and accelerate global commerce."

Merchants doing business in the UAE will be able to take advantage of Worldpay's advanced acquiring capabilities, which will be able to connect them to authorization, clearing and payments settlement, dispute management software and data insights. Merchants will also benefit from a seamless payments experience through a single point of integration—helping to increase acceptance, improve customer experience, and reduce fraud. Supporting this new market is a proof point of Worldpay's growth strategy to enhance its merchant acquiring presence in additional markets and expand its global capability.

About FIS

FIS is a leading provider of technology solutions for financial institutions and businesses of all sizes and across any industry globally. We enable the movement of commerce by unlocking the financial technology that powers the world's economy. Our employees are dedicated to advancing the way the world pays, banks and invests through our trusted innovation, system performance and flexible architecture. We help our clients use technology in innovative ways to solve business-critical challenges and deliver superior experiences for their customers. Headquartered in Jacksonville, Florida, FIS is a member of the Fortune 500 ® and the Standard & Poor's 500 ® Index. To learn more, visit www.fisglobal.com . Follow FIS on Facebook , LinkedIn and Twitter ( @FISGlobal ).

Kim Snider, 904.438.6278
Senior Vice President
FIS Global Marketing and Communications
kim.snider@fisglobal.com

News Provided by Business Wire via QuoteMedia

FIS
The Conversation (0)
Zero Candida Technologies (TSXV:ZCT)

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, announces plans to complete preclinical studies for FDA submission by Q3 2025. In accordance with FDA requirements, the company is preparing to conduct a full preclinical study of its final human-use device in up to 24 additional sheep.

The company has successfully completed a two sheep protocol pilot trial in November 2023, and is now preparing to expand the study. The ZC-1-A device was confirmed as 100% safe for use, with findings concluded from the Shamir Medical Center.

Keep reading...Show less
Zero Candida Applies to List its Shares on the TSX Venture Exchange

Zero Candida Applies to List its Shares on the TSX Venture Exchange

Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology company focused on development and commercial exploitation of a number of patents and patent applications with respect to an AI smart tampon-like device, designed to treat Candidiasis and transfer the medical information via Wi-Fi to the doctor, is pleased to announce that it has filed its application to list the Company's common shares (the " Common Shares ") on the TSX Venture Exchange (the " TSXV "). The application is available under the Company's profile on SEDAR+.

ZERO_CANDIDA_Logo

Zero Candida (formerly 1319743 B .C. Ltd.), has recently completed its business acquisition of Zero Candida Ltd., an Israeli private company ("ZC" and "Acquisition" respectively). In connection with the completion of the Acquisition, the Company changed its name to Zero Candida Technologies Inc. and split its share capital on a fifty-five thousand five hundred fifty five (55,555) common shares for one (1) common share basis, so that 36 common shares of the Company, without par value which were issued and outstanding immediately before completion of the Acquisition, were split into 2,000,000 common shares without par value. Pursuant to the terms of the Acquisition, the Company issued a total of 17,533,037 common shares (9.6165 common shares in the capital of the Company for each ordinary share in the capital of ZC) (the " Payment Shares "). Following completion of the Acquisition, ZC became a wholly-owned subsidiary of the Company. In addition, in connection with closing of the Acquisition, the Company issued 1,450,643 incentive stock options to employees of ZC (9.6165 incentive Options in exchange for each currently outstanding ZC Option). The terms of the exercise of the Options shall be consistent with the terms of the originally issued underlying ZC securities.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×